Trial · NCT00549848
Adverse events174
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 174
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergic reaction to Asparaginase | Injury, poisoning and procedural complications | PEG 3500 Units/m^2 | 28 | 206 | 36 |
| other | Allergic reaction to Asparaginase | Injury, poisoning and procedural complications | PEG 2500 Units/m^2 | 30 | 208 | 35 |
| other | Allergic reaction to Asparaginase | Injury, poisoning and procedural complications | Not Randomized | 18 | 184 | 20 |
| other | Hypertension | Vascular disorders | PEG 3500 Units/m^2 | 50 | 206 | 58 |
| other | Hypertension | Vascular disorders | PEG 2500 Units/m^2 | 47 | 208 | 56 |
| other | Hypertension | Vascular disorders | Not Randomized | 58 | 184 | 66 |
| other | Hypotension | Vascular disorders | PEG 3500 Units/m^2 | 16 | 206 | 17 |
| other | Hypotension | Vascular disorders | PEG 2500 Units/m^2 | 19 | 208 | 23 |
| other | Hypotension | Vascular disorders | Not Randomized | 10 | 184 | 13 |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | PEG 3500 Units/m^2 | 156 | 206 | 395 |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | PEG 2500 Units/m^2 | 147 | 208 | 381 |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | Not Randomized | 116 | 184 | 283 |
| other | Dehydration | Metabolism and nutrition disorders | PEG 3500 Units/m^2 | 19 | 206 | 22 |
| other | Dehydration | Metabolism and nutrition disorders | PEG 2500 Units/m^2 | 10 | 208 | 11 |
| other | Dehydration | Metabolism and nutrition disorders | Not Randomized | 13 | 184 | 14 |
| other | Diarrhea | Gastrointestinal disorders | PEG 3500 Units/m^2 | 17 | 206 | 19 |
| other | Diarrhea | Gastrointestinal disorders | PEG 2500 Units/m^2 | 12 | 208 | 13 |
| other | Diarrhea | Gastrointestinal disorders | Not Randomized | 11 | 184 | 12 |
| other | Mucositis/stomatitis (functional/symptomatic), Oral cavity | Gastrointestinal disorders | PEG 3500 Units/m^2 | 47 | 206 | 64 |
| other | Mucositis/stomatitis (functional/symptomatic), Oral cavity | Gastrointestinal disorders | PEG 2500 Units/m^2 | 63 | 208 | 78 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00549848/events